These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 35033366)
1. Identification and characterization of post-translational modifications: Clinical implications. Hermann J; Schurgers L; Jankowski V Mol Aspects Med; 2022 Aug; 86():101066. PubMed ID: 35033366 [TBL] [Abstract][Full Text] [Related]
2. Technical advances in proteomics mass spectrometry: identification of post-translational modifications. Amoresano A; Carpentieri A; Giangrande C; Palmese A; Chiappetta G; Marino G; Pucci P Clin Chem Lab Med; 2009; 47(6):647-65. PubMed ID: 19426139 [TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of protein posttranslational modifications. Farley AR; Link AJ Methods Enzymol; 2009; 463():725-63. PubMed ID: 19892200 [TBL] [Abstract][Full Text] [Related]
4. Data-independent acquisition proteomics methods for analyzing post-translational modifications. Yang Y; Qiao L Proteomics; 2023 Apr; 23(7-8):e2200046. PubMed ID: 36036492 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization. Xie X; Shah S; Holtz A; Rose J; Basisty N; Schilling B J Vis Exp; 2020 Feb; (156):. PubMed ID: 32176209 [TBL] [Abstract][Full Text] [Related]
6. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. Seo J; Lee KJ J Biochem Mol Biol; 2004 Jan; 37(1):35-44. PubMed ID: 14761301 [TBL] [Abstract][Full Text] [Related]
7. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Gajjala PR; Fliser D; Speer T; Jankowski V; Jankowski J Nephrol Dial Transplant; 2015 Nov; 30(11):1814-24. PubMed ID: 25862763 [TBL] [Abstract][Full Text] [Related]
8. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics. Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches. Kiernan UA Expert Rev Proteomics; 2007 Jun; 4(3):421-8. PubMed ID: 17552926 [TBL] [Abstract][Full Text] [Related]
10. Characterizing disease-associated changes in post-translational modifications by mass spectrometry. Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447 [TBL] [Abstract][Full Text] [Related]
11. Computational Methods in Mass Spectrometry-Based Proteomics. Li S; Tang H Adv Exp Med Biol; 2016; 939():63-89. PubMed ID: 27807744 [TBL] [Abstract][Full Text] [Related]
12. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase. Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946 [TBL] [Abstract][Full Text] [Related]
13. Top-down mass spectrometry for the analysis of combinatorial post-translational modifications. Lanucara F; Eyers CE Mass Spectrom Rev; 2013; 32(1):27-42. PubMed ID: 22718314 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric analysis of post-translational modifications (PTMs) and protein-protein interactions (PPIs). Ngounou Wetie AG; Woods AG; Darie CC Adv Exp Med Biol; 2014; 806():205-35. PubMed ID: 24952184 [TBL] [Abstract][Full Text] [Related]
15. Beyond gene expression: the impact of protein post-translational modifications in bacteria. Cain JA; Solis N; Cordwell SJ J Proteomics; 2014 Jan; 97():265-86. PubMed ID: 23994099 [TBL] [Abstract][Full Text] [Related]
16. The characterization of protein post-translational modifications by mass spectrometry. Schweppe RE; Haydon CE; Lewis TS; Resing KA; Ahn NG Acc Chem Res; 2003 Jun; 36(6):453-61. PubMed ID: 12809532 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC-MS and intact protein MS. Vilà-Rico M; Colomé-Calls N; Martín-Castel L; Gay M; Azorín S; Vilaseca M; Planas A; Canals F J Proteomics; 2015 Sep; 127(Pt B):234-46. PubMed ID: 25910794 [TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of post-translational modifications. Mann M; Jensen ON Nat Biotechnol; 2003 Mar; 21(3):255-61. PubMed ID: 12610572 [TBL] [Abstract][Full Text] [Related]